Skip to main navigation
Rapport Therapeutics, Inc. logo
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Us

SEC filing details

Financial Information
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Us

Document Details

Form
DEF 14A
Filing Date
April 23, 2026
Document Date
June 10, 2026
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Rapport Therapeutics, Inc.
Issuer
RAPPORT THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT

Investor Contact

drafts investors@rapportrx.com
© Rapport Therapeutics, Inc.
  • Link to LinkedIn opens in new window